Group One Trading
ELDN icon

Group One Trading’s Eledon Pharmaceuticals ELDN Stock Holding History

Group One Trading’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.4K Sell
24,725
-5,149
-17% -$18.7K ﹤0.01% 4885
2026
Q1 		$92K Buy
+29,874
New +$70.4K ﹤0.01% 4811
2025
Q4 		– Sell
-4,217
Closed -$10K – 8372
2025
Q3 		$10.9K Buy
4,217
+4,197
+20,985% +$12.3K ﹤0.01% 7114
2025
Q2 		$54 Sell
20
-571
-97% -$1.71K ﹤0.01% 7801
2025
Q1 		$2K Hold
591
– – ﹤0.01% 7005
2024
Q4 		$2.44K Buy
+591
New +$2.33K ﹤0.01% 6675
2024
Q2 		– Sell
-22
Closed -$45 – 6907
2024
Q1 		$45 Hold
22
– – ﹤0.01% 6866
2023
Q4 		$40 Sell
22
-4,828
-100% -$6.71K ﹤0.01% 7238
2023
Q3 		$6.64K Sell
4,850
-1,068
-18% -$1.43K ﹤0.01% 6560
2023
Q2 		$8.11K Buy
5,918
+5,318
+886% +$11.1K ﹤0.01% 6495
2023
Q1 		$1.42K Buy
+600
New +$1.61K ﹤0.01% 6696

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Group One Trading's ELDN Position: Q2 2026 in Review

Group One Trading reduced its Eledon Pharmaceuticals (ELDN) stake by 17% in Q2 2026, selling an estimated $18.7K and leaving 24,725 shares worth $97.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4885.

Group One Trading first reported a position in ELDN in Q1 2023 and has held it in 11 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Group One Trading held 24,725 shares of Eledon Pharmaceuticals worth $97.4K as of Q2 2026.
  • Group One Trading sold 5,149 Eledon Pharmaceuticals shares in Q2 2026, an estimated $18.7K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4885 holding.
  • Group One Trading first reported a position in Eledon Pharmaceuticals in Q1 2023 and has held it in 11 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.